Overview

Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose

Status:
Terminated
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
The primary efficacy objective of this study is to evaluate the effect of ferric carboxymaltose on mitochondrial gene activation pattern after 12 weeks of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Treatments:
Ferric Compounds